Click a link below to view the mailing archive as if it had been sent to you.
| 2018-01-31 12:15 | | Pharma M&A machine unstoppable: Seattle Genetics acquires Cascadian for $614m and more... |
| 2018-01-31 00:15 | | Sunovion touts pivotal Ph3 trial for Parkinson’s drug and more... |
| 2018-01-30 12:15 | | [video]Amazon, Berkshire, JPMorgan to Form Health-Care Company and more... |
| 2018-01-30 00:15 | | How Bristol-Myers and Pfizer are using real-world data to unseat warfarin and more... |
| 2018-01-29 12:15 | | Sanofi beats Novo to buy Ablynx for 3.9 billion euros in biotech M&A boom and more... |
| 2018-01-28 12:15 | | Apotex president and CEO steps down amid allegations of trade secret leaks and more... |
| 2018-01-27 12:15 | | Everything That Could Go Wrong for This Drugmaker Did and more... |
| 2018-01-27 00:15 | | Pfizer's Q4 Earnings Preview: Watching Ibrance And Prevnar Sales and more... |
| 2018-01-26 12:15 | | Everyone seems to want lower drug prices. 5 reasons why that hasn’t happened and more... |
| 2018-01-26 00:15 | | Evolus says its Botox biosimilar could be delayed by FDA issues with Daewoong plant and more... |
| 2018-01-25 12:15 | | Why The Internet Of Medical Things (IoMT) Will Start To Transform Healthcare In 2018 and more... |
| 2018-01-25 00:15 | | Why Valeant Pharmaceuticals Tumbled 10.9% Today and more... |
| 2018-01-24 12:15 | | New York sketches out $500M plan to build a biotech hub and more... |
| 2018-01-24 00:15 | | Drug discounting to insurers soars from 28% to 41% in 5 years, with no end in sight: report and more... |
| 2018-01-23 12:15 | | Biotech M&A In 2018: A Tsunami Or A Ripple? and more... |
| 2018-01-23 00:15 | | Pfizer (PFE) Set to Announce Earnings on Monday and more... |
| 2018-01-22 12:15 | | Gottlieb: Shutdown means furloughs for 42% of FDA staff and more... |
| 2018-01-22 00:15 | | Sanofi near deal to buy Bioverativ for more than $11.5 bln -WSJ and more... |
| 2018-01-21 12:15 | | 5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them and more... |
| 2018-01-21 00:15 | | Teva restructuring hits American HQ, claiming 200-plus Pennsylvania jobs and more... |
| 2018-01-19 12:15 | | AstraZeneca gives itself top marks for R&D productivity makeover — but the jury is still out and more... |
| 2018-01-19 00:15 | | Novartis ties a new round of biosimilar development programs to a partnership deal with India’s Biocon and more... |
| 2018-01-18 12:15 | | Medtronic logs wins in overcharging lawsuit, defibrillator case fees and more... |
| 2018-01-18 00:15 | | Is Juno worth a $10B-$12B buyout price? Analysts see megabucks deal in the making on reported Celgene talks and more... |
| 2018-01-17 12:15 | | Celgene is reportedly in talks to buy Juno Therapeutics and more... |
| 2018-01-17 00:15 | | GlaxoSmithKline eyes $1.7B bid for respiratory partner Vectura: report and more... |
| 2018-01-16 12:15 | | Merck's Keytruda extends lung cancer survival in combination trial and more... |
| 2018-01-16 00:15 | | Three Interviews From the J.P. Morgan Healthcare Conference and more... |
| 2018-01-15 12:15 | | Can a hip replacement kill you: lack of regulation in the med device industry and more... |
| 2018-01-14 12:15 | | Decoding cancer-linked enzyme could lead to better EGFR cancer drugs and more... |
| 2018-01-14 00:15 | | Closing JPM18: Winners and losers, brighter days for neuroscience and more... |
| 2018-01-13 00:15 | | Flu season is shaping up as one of the worst in years, officials say and more... |
| 2018-01-12 12:15 | | Ex-Insys employee seeks ban on mentioning 'opioid crisis' at trial and more... |
| 2018-01-12 00:15 | | Eli Lilly, sporting a lower tax rate, scouts smaller deals in immunology, cancer and more... |
| 2018-01-11 12:15 | | Teva to cut up to 40 manufacturing sites, with 25 slated to go in next 2 years and more... |
| 2018-01-11 00:15 | | Lilly CEO: With pharma friends in high places, it's 'time for action' to ease drug costs and more... |
| 2018-01-10 12:15 | | J&J chief Gorksy bullish on tax reform, plans $16B in repatriated overseas cash and more... |
| 2018-01-10 00:15 | | Drug pricing pressure isn't likely to get worse: Merck CEO and more... |
| 2018-01-09 12:15 | | The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past and more... |
| 2018-01-09 00:15 | | The Winners And Losers Of JP Morgan Monday and more... |
| 2018-01-08 12:15 | | Novo Nordisk puts $3B on the table for Ablynx and more... |
| 2018-01-08 00:15 | | Pfizer is axing its neurosciences division, laying off 300 and discarding new drugs and more... |
| 2018-01-07 00:15 | | Novartis Pharma Ex-CEO takes three roles in two days and more... |
| 2018-01-06 00:15 | | More Than 100 Days After Hurricane Maria, Drug Shortages Situation Expected to Improve and more... |
| 2018-01-05 12:15 | | 2017 Was A Banner Year For Innovation. But Will It Be Short-Lived? and more... |
| 2018-01-05 00:15 | | Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most and more... |
| 2018-01-04 12:15 | | 3 issues to watch in global health in 2018 and more... |
| 2018-01-04 00:15 | | Why Insys Therapeutics Inc Is Up Double Digits for the Second Straight Day and more... |
| 2018-01-03 12:15 | | Spark prices its gene therapy as most expensive U.S. medicine — but with plans to ease cost concerns and more... |
| 2018-01-03 00:15 | | In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M and more... |
| 2018-01-02 12:15 | | Star drugs like BMS’ Opdivo, AstraZeneca’s Lynparza will get speedy OKs in China this year, new report predicts and more... |
| 2018-01-02 00:15 | | The Intrinsic Value Of Gilead Science and more... |
